Improve Medical

Improve Medical (阳普医疗), formally Yangpu Medical Technology Co., Ltd., is a Chinese medical device and in-vitro diagnostics (IVD) company founded in 1996 and headquartered in Zhuhai's Hengqin New Area, with a major office in Guangzhou. It describes itself as a high-tech enterprise engaged in research on pre-analytical specimen variation control, and has become a benchmark in China's venous specimen collection field. The company listed on the Shenzhen Stock Exchange ChiNext board in 2009 under stock code 300030. Starting from its vacuum blood collection system business, Improve Medical has built a product and service portfolio covering the full chain of clinical laboratory specimen collection and data management, and has extended into tumor companion diagnostics centered on molecular diagnostics. Its offerings include specimen management systems, intelligent blood collection management solutions, clinical laboratory diagnostic platforms, thromboelastography analyzers, peripheral blood collection systems, cell-free DNA preservation tubes, vacuum blood collection systems, automated decapping and capping machines, and flow cytometry molecular diagnostic platforms. It also provides hospital digital overall solutions for specimen collection, transport, sorting and process information monitoring. The company markets its products and services to nearly ten thousand well-known medical institutions, with a presence in more than one hundred countries and regions worldwide. Its brand positioning centers on 'caring for human health' and providing precise management of medical specimens through automation, intelligence and informatization. Improve Medical has received recognition such as being rated a Guangdong Province Quality Credit Class A medical device manufacturer in 2020, and its chairman received an award for outstanding contribution to epidemic research during the COVID-19 pandemic. The company also entered the U.S. list of sellable virus transport medium (VTM) enterprises in 2020.

Improve Medical (阳普医疗) was founded in 1996 as a high-tech enterprise dedicated to research on pre-analytical specimen variation control. Over the following decades, it grew into a benchmark in China's venous specimen collection industry. In 2009, the company listed on the Shenzhen Stock Exchange ChiNext board under stock code 300030, giving it a public platform to expand. Leveraging its listing, Improve Medical started from its vacuum blood collection system business and built a portfolio covering the entire chain of clinical laboratory specimen collection and data management. It then extended into tumor companion diagnostics centered on molecular diagnostics, aiming to build a patient-centric medical service platform. Its products and services reached nearly ten thousand medical institutions and markets in more than one hundred countries and regions. In 2020, during the COVID-19 pandemic, the company entered the U.S. list of sellable virus transport medium (VTM) enterprises, and its chairman received an award for outstanding contribution to epidemic research in Huangpu District. In 2021, the company assisted Dongguan by completing nearly one million tests in three days, and it was rated a Guangdong Province 2020 Quality Credit Class A medical device manufacturer. It also signed a strategic cooperation agreement with the Guangdong Hospital Association and partnered with Guangzhou Yibo to develop smart healthcare. The company continues to operate with headquarters in Zhuhai's Hengqin New Area and a major office in Guangzhou.

• 2021

  Assisted Dongguan, completing nearly one million tests in 3 days.

• 2021

  Rated Guangdong Province 2020 Quality Credit Class A medical device manufacturer.

• 2021

  Signed strategic cooperation agreement with Guangdong Hospital Association.

• 2020

  Entered the U.S. list of sellable virus transport medium (VTM) enterprises.

• 2020

  Chairman received award for outstanding contribution to epidemic research in Huangpu District.

• 2009

  Listed on the Shenzhen Stock Exchange ChiNext board under stock code 300030.

• 1996

  Company founded as a high-tech enterprise focused on pre-analytical specimen variation control.

High-tech enterprise focused on pre-analytical specimen variation control, providing integrated solutions for clinical laboratory specimen collection, data management, and molecular diagnostics.

• Vacuum blood collection system

  Core product line for venous blood collection.

• Peripheral blood collection system

  System for capillary blood collection.

• Intelligent blood collection management solution

  Automated solution for managing blood collection workflows.

• Thromboelastography analyzer

  Diagnostic instrument for coagulation analysis.

• Cell-free DNA preservation tube

  Tube for preserving cell-free DNA in blood samples.

• Vacuum blood collection tube decapping machine

  Automated machine for removing caps from vacuum blood collection tubes.

• Vacuum blood collection tube capping machine

  Automated machine for capping vacuum blood collection tubes.

• Flow cytometry molecular diagnostic platform

  Platform for molecular diagnostics using flow cytometry.

• Hospital digital overall solution

  Integrated solution for specimen collection, transport, sorting and process monitoring.

1. 1首页 - 阳普医疗科技股份有限公司improve-medical.com
2. 2企业文化_走进阳普_阳普医疗科技股份有限公司improve-medical.com
3. 3末梢采血系统improve-medical.com
4. 4集团介绍_走进阳普_阳普医疗科技股份有限公司improve-medical.com